Consolidated Portfolio Review Corp Makes New $318,000 Investment in The Clorox Company (NYSE:CLX)

Consolidated Portfolio Review Corp acquired a new position in shares of The Clorox Company (NYSE:CLX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 1,956 shares of the company's stock, valued at approximately $318,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Insight Folios Inc boosted its holdings in Clorox by 3.0% during the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company's stock valued at $358,000 after acquiring an additional 63 shares during the period. HCR Wealth Advisors boosted its holdings in Clorox by 1.0% during the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company's stock valued at $1,116,000 after acquiring an additional 68 shares during the period. Empower Advisory Group LLC boosted its holdings in Clorox by 4.5% during the 3rd quarter. Empower Advisory Group LLC now owns 1,823 shares of the company's stock valued at $297,000 after acquiring an additional 78 shares during the period. Aviance Capital Partners LLC boosted its holdings in Clorox by 2.7% during the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company's stock valued at $502,000 after acquiring an additional 80 shares during the period. Finally, Lindbrook Capital LLC boosted its holdings in Clorox by 9.9% during the 3rd quarter. Lindbrook Capital LLC now owns 977 shares of the company's stock valued at $159,000 after acquiring an additional 88 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Performance

Shares of CLX stock traded up $0.30 during trading hours on Wednesday, hitting $148.66. The stock had a trading volume of 842,689 shares, compared to its average volume of 1,340,792. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.62. The stock's 50 day moving average is $160.30 and its 200 day moving average is $159.26. The firm has a market capitalization of $18.40 billion, a PE ratio of 40.62, a PEG ratio of 2.52 and a beta of 0.42.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the firm earned $2.16 earnings per share. As a group, research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.28%. The ex-dividend date is Wednesday, January 29th. Clorox's dividend payout ratio (DPR) is presently 133.33%.

Analyst Ratings Changes

CLX has been the subject of a number of research analyst reports. Evercore ISI raised their target price on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. StockNews.com cut Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. TD Cowen raised Clorox from a "sell" rating to a "hold" rating and boosted their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Barclays boosted their price objective on Clorox from $130.00 to $140.00 and gave the stock an "underweight" rating in a research report on Wednesday, February 5th. Finally, JPMorgan Chase & Co. boosted their price objective on Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 4th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $158.21.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.